HIV/AIDS Clinical Trials in Chicago

Showing 201-220 of 553 trials

Safety of Recombinant HIV Vaccines in HIV Infected Young Adults on Stable Therapy

NCT00107549

The purpose of this study is to determine the safety of two recombinant HIV vaccines in HIV infected young adults on stable anti-HIV therapy.

HIV Infections

National Institute of Allergy and Infectious Diseases (NIAID)20 participants

Los Angeles, California, United States • Los Angeles, California, United States • Aurora, Colorado, United States +6 more locations

COMPLETEDPhase 12.2 miles

Safety and Effectiveness of Lopinavir/Ritonavir in HIV Infected Infants

NCT00038480

The purpose of this study is to find out if the drug lopinavir/ritonavir (LPV/RTV) is safe and well tolerated in HIV infected infants. This study will also determine the most effective dose of LPV/RTV for infants.

HIV Infections

National Institute of Allergy and Infectious Diseases (NIAID)31 participants

Oakland, California, United States • San Francisco, California, United States • Aurora, Colorado, United States +14 more locations

Safety of Recombinant HIV Vaccines in HIV Infected Young Adults on Stable Therapy

Safety and Effectiveness of Lopinavir/Ritonavir in HIV Infected Infants

HIV/AIDS Trials in Other Cities

Safety of the Candidate Vaccine C4-V3 Alone or With Interleukin-12 (IL-12) in HIV-Infected Patients Receiving Effective Anti-HIV Drug Therapy

Study of Viral Load Decay Rates in HIV Infected Participants Starting Treatment With Raltegravir (RAL) and Emtricitabine/Tenofovir Disoproxil Fumarate (TDF)

A Study to Evaluate the Effects of Interleukin-12 (rhIL-12) in HIV-Positive Patients With CD4 Cell Counts Less Than 50 Cells/mm3 or 300-500 Cells/mm3

A Study to Learn More About MAC Disease and the Use of Anti-HIV Drugs in Patients With Advanced HIV Infection

A Study to Evaluate the Effect of Nandrolone Decanoate in Women With HIV-Associated Weight Loss

A Study to Test the Safety of Recombinant Interleukin-2 (rIL-2) in HIV-Infected Children

Drug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative Volunteers

Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People

A Study on Possible Interactions Between Protease Inhibitors (Anti-HIV Drugs) and Drugs Which Lower the Level of Fat in Your Blood

Safety and Effectiveness of Ritonavir Plus Lamivudine Plus Zidovudine in HIV-Infected Pregnant Women and Their Babies

A Study to Test the Safety of Three Experimental HIV Vaccines

Adding New Drugs for HIV Infected Patients Failing Current Therapy

A Study to Evaluate the Ability of TNFR:Fc to Decrease the Amount of IL-6 (Interleukin-6) and TNF-alpha (Tumor Necrosis Factor) in HIV-Infected Patients

A Study of Dextran Sulfate in HIV-Infected Patients and in Patients With AIDS or AIDS Related Complex (ARC)

Safety, Tolerability, and Anti-HIV Activity of DMP 266 (Efavirenz) in Combination With Nelfinavir in HIV-Positive Children

A Study of Ritonavir (an Anti-HIV Drug) in HIV-Positive Infants and Children

A Study to Evaluate the Safety and Tolerance of Nelfinavir (NFV) Given With Zidovudine (ZDV) and Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants

Safety of and Immune Response to a DNA HIV Vaccine (VRC-HIVDNA009-00-VP) in HIV Infected Individuals With Acute HIV Infection

Other Conditions in Chicago